Mesoblast Retires Senior Debt with Non-Dilutive, Lower Cost, Five-Year Credit Line
December 29, 2025 18:57 ET | Source: Mesoblast Limited Mesoblast has option…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
Relativity’s Justice for Change Program Reaches Five-Year Milestone at Relativity Fest 2025
News Summary: The program has supported 250+ matters, with more than 19.2…
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms…
